Exclusivity Extended into December 2042 Kansas City, Kan. — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and …
Copyright © CB Herald. 2026
